CCAAT/enhancer binding protein β is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques

American Journal of Pathology

Volumn 173, Issue 1, 2008, Pages 106-118

  Mohan, Mahesh ^a   Aye, Pyone P ^a   Borda, Juan T ^a   Alvarez, Xavier ^a   Lackner, Andrew A ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CHROMATIN IMMUNOPRECIPITATION; CHRONIC DIARRHEA; COLITIS; COLON; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; GASTROINTESTINAL INFECTION; GENE EXPRESSION; IMMUNOPHENOTYPING; IN VIVO STUDY; JEJUNUM; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION; WASTING SYNDROME;

EID: 46749123134     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080108     Document Type: Article

References (65)

1. Lackner AA, Veazey RS: Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med 2007, 58:461-476
2. + T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431
3. + T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004, 200:761-770
4. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200:749-759
5. Mónkemüller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM: Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci 2005, 50:230-234
6. Miao YM, Gazzard BG: Management of protozoal diarrhoea in HIV disease. HIV Med 2000, 1:194-199
7. Wilcox CM: Gastrointestinal manifestations of AIDS. Nutr Clin Pract 2004, 19:356-364
8. Guarino A, Bruzzese E, De Marco G, Buccigrossi V: Management of gastrointestinal disorders in children with HIV infection. Paediatr Drugs 2004, 6:347-362
9. Sestak K: Chronic diarrhea and AIDS: insights into studies with nonhuman primates. Curr HIV Res. 2005, 3:199-205
10. Heise C, Vogel P, Miller CJ, Halsted CH, Dandekar S: Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol 1993, 142:1759-1771
11. Heise C, Miller CJ, Lackner A, Dandekar S: Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 1994, 169:1116-1120
12. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M: Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol 1994, 145:428-439
13. Kewenig S, Schneider T, Hohloch K, Lampe-Dreyer K, Ullrich R, Stolte N, Stahl-Hennig C, Kaup FJ, Stallmach A, Zeitz M: Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999, 116:1115-1123
14. MacDonald TT, Spencer J: Cell-mediated immune injury in the intestine. Gastroenterol Clin North Am 1992, 21:367-386
15. Field M: T cell activation alters intestinal structure and function. J Clin Invest 2006, 116:2580-2582
16. Brenchley JM, Price DA, Douek DC: HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006, 7:235-239
17. Ishihara K, Hirano T: IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002, 13:357-368
18. Poli G: Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. Eur J Clin Invest 1999, 29:723-732
19. Connolly NC, Riddler SA, Rinaldo CR: Proinflammatory cytokines in HIV disease - a review and rationale for new therapeutic approaches. AIDS Rev 2005, 7:168-180
20. McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, Poles M, Anton P: Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 2004, 37:1228-1236
21. Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ: Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 2005, 79:12164-12172
22. Mohan M, Aye PP, Borda JT, Alvarez X, Lackner AA: Gastrointestinal disease in SIV-infected rhesus macaques is characterized by proinflammatory dysregulation of the IL-6-JAK-STAT3 pathway. Am J Pathol 2007, 171:1952-1965
23. Gabay C: Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006, 8(Suppl 2):S3:1-6
24. Niehof M, Streetz K, Rakemann T, Bischoff SC, Manns MP, Horn F, Trautwein C: Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J Biol Chem 2001, 276:9016-9027
25. Ito H: IL-6 and Crohn's disease. Curr Drug Targets Inflamm Allergy 2003, 2:125-130
26. Johnson PF, Williams SC: CCAAT/enhancer binding (C/EBP) proteins. Liver Gene Expression. Edited by EF Tronche, M Yaniv. Austin, RG Landes Company, 1994, p 231-258
27. Cooper C, Henderson A, Artandi S, Avitahl N, Calame K: Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res 1995, 23:4371-4377
28. Descombes P, Schibler U: A liver-enriched transcriptional activator protein. LAP, and a transcriptional inhibitory protein LIP, are translated from the same mRNA. Cell 1991, 67:569-579
29. Wu KK, Liou JY, Cieslik K: Transcriptional control of COX-2 via C/EBPbeta. Arterioscler Thromb Vasc Biol 2005, 25:679-685
30. Poli V: The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998, 273:29279-29282
31. Ramji DP, Foka P: CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575
32. Mukerjee R, Sawaya BE, Khalili K, Amini S: Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter. J Cell Biochem 2007, 100:1210-1216
33. Zhang Y, Rom WN: Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol 1993, 13:3831-3837
34. Pope RM, Leutz A, Ness SA: C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 1994, 94:1449-1455
35. Isshiki H, Akira S, Tanabe O, Nakajima T, Shimamoto T, Hirano T, Kishimoto T: Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol 1990, 10:2757-2764
36. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993, 90:10193-10197
37. Yamamoto K, Takeshima H, Hamada K, Nakao M, Kino T, Nishi T, Kochi M, Kuratsu J, Yoshimura T, Ushio Y: Cloning and functional characterization of the 5′-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) gene. Essential role of 5′-untranslated region in tissue-specific expression. J Biol Chem 1999, 274:4646-4654
38. Rosati M, Valentin A, Patenaude DJ, Pavlakis GN: CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol 2001, 167:1654-1662
39. Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC: Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat. Biomed Pharmacother 2003, 57:34-40
40. Henderson AJ, Zou X, Calame KL: C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995, 69:5337-5344
41. Henderson AJ, Connor RI, Calame KL: C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 1996, 5:91-101
42. Henderson AJ, Calame KL: CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci USA 1997, 94:8714-8719
43. Hogan TH, Krebs FC, Wigdahl B: Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. J Neurovirol 2002, 8(Suppl 2):21-26
44. Barber SA, Gama L, Dudaronek JM, Voelker T, Tarwater PM, Clements JE: Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J Infect Dis 2006, 193:963-970
45. Honda Y, Rogers L, Nakata K, Zhao BY, Pine R, Nakai Y, Kurosu K, Rom WN, Weiden M: Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998, 188:1255-1265
46. Weiden M, Tanaka N, Qiao Y, Zhao BY, Honda Y, Nakata K, Canova A, Levy DE, Rom WN, Pine R: Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 2000, 165:2028-2039
47. Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse DB, Shioda T, Rom WN, Weiden M: Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002, 195:495-505
48. Sestak K, Merritt CK, Borda J, Saylor E, Schwamberger SR, Cogswell F, Didier ES, Didier PJ, Plauche G, Bohm RP, Aye PP, Alexa P, Ward RL, Lackner AA: Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infect Immun 2003, 71:4079-4086
49. Ramesh G, Alvarez X, Borda JT, Aye PP, Lackner AA, Sestak K: Visualizing cytokine-secreting cells in situ in the rhesus macaque model of chronic gut inflammation. Clin Diagn Lab Immunol 2005, 12:192-197
50. + T cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000, 74:57-64
51. Veazey RS, Lackner AA: Getting to the guts of HIV pathogenesis. J Exp Med 2004, 200:697-700
52. Li Q, Schacker T, Carlis J, Beilman G, Nguyen P, Haase AT: Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J Infect Dis 2004, 189:572-582
53. Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, Prindiville T, Dandekar S: Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci USA 2005, 102:9860-9865
54. George MD, Reay E, Sankaran S, Dandekar S: Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol 2005, 79:2709-2719
55. George MD, Verhoeven D, McBride Z, Dandekar S: Gene expression profiling of gut mucosa and mesenteric lymph nodes in simian immunodeficiency virus-infected macaques with divergent disease course. J Med Primatol 2006, 35:261-269
56. Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S: Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006, 80:8236-8247
57. Dandekar S: Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep 2007, 4:10-15
58. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371
59. Bradley MN, Zhou L, Smale ST: C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol 2003, 23:4841-4858
60. Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B: Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 2003, 9:55-68
61. Silver S, Wahl SM, Orkin BA, Orenstein JM: Changes in circulating levels of HIV, CD4, and tissue expression of HIV in a patient with recent-onset ulcerative colitis treated by surgery. Case report. J Hum Virol 1999, 2:52-57
62. Smith PD, Meng G, Salazar-Gonzalez JF, Shaw GM: Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J Leukoc Biol 2003, 74:642-649
63. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H: Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994, 35:669-674
64. Wu KK: Control of COX-2 and iNOS gene expressions by aspirin and salicylate. Thromb Res 2003, 110:273-276
65. Wu KK: Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 2006, 96:417-422